Literature DB >> 30406290

Assessment of a guideline-based heart substructures delineation in left-sided breast cancer patients undergoing adjuvant radiotherapy : Quality assessment within a randomized phase III trial testing a cardioprotective treatment strategy (SAFE-2014).

Giulio Francolini1, Isacco Desideri2, Icro Meattini1, Carlotta Becherini1, Francesca Terziani1, Emanuela Olmetto1, Camilla Delli Paoli1, Donato Pezzulla1, Mauro Loi1, Pierluigi Bonomo1, Daniela Greto1, Silvia Calusi3, Marta Casati4, Stefania Pallotta4, Lorenzo Livi1.   

Abstract

BACKGROUND AND
PURPOSE: In our institute, breast cancer patients undergoing adjuvant treatment are included in a protocol aimed to reduce cardiovascular morbidity (SAFE-2014, NCT2236806), assessing preclinical heart damage with heart speckle-tracking ultrasound. To develop a dose constraint related to subclinical heart damage, a reliable delineation of heart substructures based on a pre-existing guideline was made. PATIENTS AND METHODS: Heart substructures of 16 left-sided breast cancer patients included in the SAFE protocol were delineated by five operators. For each substructure, a multi-contour delineation based on a majority vote algorithm (MCD) was created. A consensus-based delineation (CBD) was developed by an independent team of two blinded operators. Dice similarity coefficients (DSC) between volumes delineated by different operators and the MCD were collected and reported, as well as DSC between CBD and MCD.
RESULTS: Mean DSCs between heart chambers delineated by each operator and the corresponding MCDs ranged between 0.78 and 0.96. Mean DSC between substructures delineated by all single operators and the corresponding MCD ranged between 0.84 and 0.94. Mean DSC between CBD and the corresponding MCD ranged from 0.89 to 0.97.
CONCLUSION: Results showed low inter-observer variability of heart substructure delineation. This constitutes an external validation of the contouring atlas used, allowing a reliable dosimetric assessment of these volumes within the SAFE-2014 trial.

Entities:  

Keywords:  Anthracyclines; Bisoprolol; Cardiovascular diseases; Ramipril; Trastuzumab

Mesh:

Substances:

Year:  2018        PMID: 30406290     DOI: 10.1007/s00066-018-1388-x

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  14 in total

1.  Development and validation of a heart atlas to study cardiac exposure to radiation following treatment for breast cancer.

Authors:  Mary Feng; Jean M Moran; Todd Koelling; Aamer Chughtai; June L Chan; Laura Freedman; James A Hayman; Reshma Jagsi; Shruti Jolly; Janice Larouere; Julie Soriano; Robin Marsh; Lori J Pierce
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-04-24       Impact factor: 7.038

2.  Morphometric analysis of white matter lesions in MR images: method and validation.

Authors:  A P Zijdenbos; B M Dawant; R A Margolin; A C Palmer
Journal:  IEEE Trans Med Imaging       Date:  1994       Impact factor: 10.048

3.  Automatic delineation for replanning in nasopharynx radiotherapy: what is the agreement among experts to be considered as benchmark?

Authors:  Gian Carlo Mattiucci; Luca Boldrini; Giuditta Chiloiro; Giuseppe Roberto D'Agostino; Silvia Chiesa; Fiorenza De Rose; Luigi Azario; Danilo Pasini; Maria Antonietta Gambacorta; Mario Balducci; Vincenzo Valentini
Journal:  Acta Oncol       Date:  2013-08-19       Impact factor: 4.089

4.  Automatic segmentation of breast in prone position: Correlation of similarity indexes and breast pendulousness with dose/volume parameters.

Authors:  Giovanna Dipasquale; Xinzhuo Wang; Vanessa Chatelain-Fontanella; Vincent Vinh-Hung; Raymond Miralbell
Journal:  Radiother Oncol       Date:  2016-05-10       Impact factor: 6.280

Review 5.  SAFE trial: an ongoing randomized clinical study to assess the role of cardiotoxicity prevention in breast cancer patients treated with anthracyclines with or without trastuzumab.

Authors:  Icro Meattini; Giuseppe Curigliano; Francesca Terziani; Carlotta Becherini; Mario Airoldi; Giacomo Allegrini; Domenico Amoroso; Sandro Barni; Carmelo Bengala; Valentina Guarneri; Paolo Marchetti; Francesca Martella; Pierluigi Piovano; Agnese Vannini; Isacco Desideri; Roberto Tarquini; Giorgio Galanti; Giuseppe Barletta; Lorenzo Livi
Journal:  Med Oncol       Date:  2017-03-31       Impact factor: 3.064

6.  Strain Imaging Detects Dose-Dependent Segmental Cardiac Dysfunction in the Acute Phase After Breast Irradiation.

Authors:  Queenie Lo; Leia Hee; Vikneswary Batumalai; Christine Allman; Peter MacDonald; Denise Lonergan; Geoff P Delaney; Liza Thomas
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-05-26       Impact factor: 7.038

7.  Supervised machine learning-based classification scheme to segment the brainstem on MRI in multicenter brain tumor treatment context.

Authors:  Jose Dolz; Anne Laprie; Soléakhéna Ken; Henri-Arthur Leroy; Nicolas Reyns; Laurent Massoptier; Maximilien Vermandel
Journal:  Int J Comput Assist Radiol Surg       Date:  2015-07-24       Impact factor: 2.924

8.  Risk of ischemic heart disease in women after radiotherapy for breast cancer.

Authors:  Sarah C Darby; Marianne Ewertz; Paul McGale; Anna M Bennet; Ulla Blom-Goldman; Dorthe Brønnum; Candace Correa; David Cutter; Giovanna Gagliardi; Bruna Gigante; Maj-Britt Jensen; Andrew Nisbet; Richard Peto; Kazem Rahimi; Carolyn Taylor; Per Hall
Journal:  N Engl J Med       Date:  2013-03-14       Impact factor: 91.245

9.  Variability of target and normal structure delineation for breast cancer radiotherapy: an RTOG Multi-Institutional and Multiobserver Study.

Authors:  X Allen Li; An Tai; Douglas W Arthur; Thomas A Buchholz; Shannon Macdonald; Lawrence B Marks; Jean M Moran; Lori J Pierce; Rachel Rabinovitch; Alphonse Taghian; Frank Vicini; Wendy Woodward; Julia R White
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-03-01       Impact factor: 7.038

10.  A cardiac contouring atlas for radiotherapy.

Authors:  Frances Duane; Marianne C Aznar; Freddie Bartlett; David J Cutter; Sarah C Darby; Reshma Jagsi; Ebbe L Lorenzen; Orla McArdle; Paul McGale; Saul Myerson; Kazem Rahimi; Sindu Vivekanandan; Samantha Warren; Carolyn W Taylor
Journal:  Radiother Oncol       Date:  2017-02-21       Impact factor: 6.280

View more
  2 in total

Review 1.  The impact of modern radiotherapy on long-term cardiac sequelae in breast cancer survivor: a focus on deep inspiration breath-hold (DIBH) technique.

Authors:  V Salvestrini; G C Iorio; P Borghetti; F De Felice; C Greco; V Nardone; A Fiorentino; F Gregucci; I Desideri
Journal:  J Cancer Res Clin Oncol       Date:  2021-12-01       Impact factor: 4.553

Review 2.  Emerging Challenges of Radiation-Associated Cardiovascular Dysfunction (RACVD) in Modern Radiation Oncology: Clinical Practice, Bench Investigation, and Multidisciplinary Care.

Authors:  Moon-Sing Lee; Dai-Wei Liu; Shih-Kai Hung; Chih-Chia Yu; Chen-Lin Chi; Wen-Yen Chiou; Liang-Cheng Chen; Ru-Inn Lin; Li-Wen Huang; Chia-Hui Chew; Feng-Chun Hsu; Michael W Y Chan; Hon-Yi Lin
Journal:  Front Cardiovasc Med       Date:  2020-02-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.